Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesAntiplatelet therapy for prevention of recurrent stroke
Current Treatment Options in Neurology, 10/29/09
Badruddin A et al. – When choosing an antiplatelet agent for this purpose, clinicians should take into account cost, side effect profile, medical comorbidity, and patient preference. To prevent recurrent stroke, aspirin alone (50–325 mg/d), a combination of aspirin (25 mg) plus extended–release dipyridamole (200 mg), given twice daily, or clopidogrel (75 mg/d) may be used as initial treatment. Prasugrel, a new thienopyridine derivative, more quickly and consistently inhibits platelets than clopidogrel. In stroke patients, prasugrel may be associated with a higher risk of brain hemorrhage, so it may not be indicated when there is a history of cerebrovascular disease.
Related Articles
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
Hypertension Research, 11/13/09
Relevance Score: 81%
Stroke-related dementia: Rates, risk factors and implications for future research
Maturitas, 11/11/09
Relevance Score: 81%
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy, 10/20/09
Relevance Score: 81%
Ischemic stroke and hyperhomocysteinemia: truth or myth
Acta Neurologica Belgica, 10/21/09
Relevance Score: 80%
Low Ankle-Brachial Index Predicts Cardiovascular Risk After Acute Ischemic Stroke or Transient Ischemic Attack
Stroke, 10/20/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes
Diabetes Care, 11/25/09
A Comparative Effectiveness Evaluation of Percutaneous Adhesiolysis and Epidural Steroid Injections in Managing Lumbar Post Surgery Syndrome: A Randomized, Equivalence Controlled Trial
Pain Physician, 11/25/09
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis
Cancer Causes and Control, 11/25/09
Effectiveness of Public Report Cards for Improving the Quality of Cardiac Care: The EFFECT Study: A Randomized Trial
JAMA, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor